Isla Pharmaceuticals
San Juan, US · Founded 2017 · Delaware corporation
Founders & leadership
AH
Albert HansenNamed on SEC filing
WJ
William James GarnerNamed on SEC filing
DC
David Charles FosterNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.7M disclosed across 2 rounds · 2018–2020
▶$562.9KraisedMar 2020 · 6 investors · PharmaceuticalsRule 506(b)
▶$562.9KraisedMar 2020 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David Charles FosterExecutive Officer, Director
- Albert HansenDirector
- Paul Donald Richard MacLemanDirector
- Joseph Isadore GreenDirector
- William James GarnerDirector
- Offering amount
- $1.5M
- Amount sold
- $562.9K
- Minimum investment
- $12.5K
- Proceeds to insiders
- $75K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2019 · 16 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedFeb 2019 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Albert HansenDirector
- William James GarnerDirector
- David Charles FosterExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Minimum investment
- $6.1K
- Proceeds to insiders
- $40K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Isla Pharmaceuticals raised?
- Isla Pharmaceuticals has disclosed $1.7M raised across 2 rounds.
- Where is Isla Pharmaceuticals headquartered?
- Isla Pharmaceuticals is headquartered in San Juan, US.